• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Metallic Make Up for Orthopedic Materials

    Infection Control Strategies Offer a Plan of Pathogen Attack

    Multi-Dimensional Approaches to Orthopedic Implant Manufacturing

    Orthopedic Implants Are Fit to Print

    Fitting the Mold of Ortho Device Manufacturing
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthobiologics Market to Top $10.3 Billion by 2030

    Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus

    Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial

    Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute

    Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Former BD, J&J Executives Join Acuitive Technologies Board

    Augmedics Debuts New Features, Indications for xvision Platform

    Artelon Closes $20M Series B Funding

    Orthofix Unveils Seven-Year Outcome Data for M6-C Artificial Cervical Disc

    The Silicon Valley Bank Collapse and Its Impact on Compliance
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Designing Scalable Patient-Specific Surgical Cutting Guides

    3D Printing Provides Stepping Stones for New Orthopedic Footwear Innovations

    How Honeywell's Spectra Fiber is Used in Orthopedics, TAVR, and More

    All About Reverse Shoulder Devices: Analyzing the Factors Driving Their Popularity

    Evolution of the Global Orthopedic Biomaterials Market
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Life Science Outsourcing Inc.

    Tiodize

    Braxton Manufacturing

    AV&R

    Modern Plastics
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Breaking News

    Bioventus Amends CartiHeal Acquisition Structure

    Revised agreement reduces the closing payment to $50 million from the original $315 million price tag.

    Michael Barbella, Managing Editor06.23.22
    Bioventus Inc. is amending its pending CartiHeal purchase agreement to ease the financial burden on both the company and its stockholders.

    “CartiHeal represents an important breakthrough for the treatment of osteoarthritis and osteochondral defects of the knee with significant long-term potential, and we are excited to have reached an amendment that we believe will be favorable to our stakeholders and enable us to complete the acquisition,” Bioventus CEO Ken Reali said. “The ability to defer a significant portion of the upfront cash consideration allows us to continue investing in our near-term strategy for growth while maintaining financial flexibility. Bioventus possesses multiple short- and mid-term growth drivers that are further enhanced by CartiHeal, and we continue to work towards realizing the potential of our portfolio to deliver sustained double-digit growth and margin expansion.”
     
    The amended acquisition agreement reduces Bioventus' closing payment to $50 million (in addition to $50 million deposited into escrow last year) from the original $315 million that was previously agreed. The remaining $215 million of the purchase price (the deferred amount) will instead be paid to CartiHeal stockholders upon the earlier achievement of certain milestones or on certain installment payment dates. The deferred amount will be paid in five tranches commencing in 2023 and ending no later than 2027.
     
    Bioventus will pay interest on each tranche of the deferred amount at 8% annually until the tranche is paid. Additionally, the $135 million owed to CartiHeal stockholders upon achieving $100 million in trailing 12-month sales will now be payable upon achieving $75 million in trailing 12-month sales.
     
    Bioventus expects to close the acquisition by the end of July 2022, subject to closing conditions, with a $108 million up-front payment to CartiHeal’s stockholders (inclusive of the $50 million previously deposited into escrow by Bioventus and in addition to approximately $8 million of CartiHeal’s transaction-related fees and expenses that Bioventus has agreed to pay). The company will finance the payment due at closing with additional debt. Bioventus is finalizing an amendment to its existing Credit and Guaranty Agreement to increase its current term loan to facilitate the deal's closing. Deferred amount payments are anticipated to be made through the company’s free cash flow and expansion of its existing credit facility.
     
    Bioventus delivers products that help people heal quickly and safely. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies, and surgical solutions. 
      Loading, Please Wait..

      Trending
      • Treace To Buy RPM-3D Tech For Up To $30 Million
      • Nevro Names Stryker Exec Greg Siller As Chief Commercial Officer
      • FDA Approves Centinel Spine's Two-level Prodisc L Total Disc Replacement
      • Cementless Hip Implants Are Gradually Losing Their Popularity In Europe
      • Spineart, ECential Robotics Begin Partnership
      Breaking News
      • Orthobiologics Market to Top $10.3 Billion by 2030
      • Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
      • Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
      • Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute
      • Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer
      View Breaking News >
      CURRENT ISSUE

      May/June 2023

      • Metallic Make Up for Orthopedic Materials
      • Infection Control Strategies Offer a Plan of Pathogen Attack
      • Multi-Dimensional Approaches to Orthopedic Implant Manufacturing
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Sempera Organics and Alchemist Labs Announce Partnership for Mushroom Testing
      Nektium Expands International Distribution Network for Botanical Extracts
      Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient
      Coatings World

      Latest Breaking News From Coatings World

      PPG’s New Paint for a New Start Initiative to Beautify Schools Worldwide with Colorful Makeovers
      Powder Technology, Inc. Announces New Electrical Coating
      Michelman Chosen as Inaugural Recipient of Innovation Research Interchange (IRI) Excellence Award
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      ISO 13485:2016 Certification Granted to Boston BioProducts
      Paul Colvin Joins Ora Inc. as Chief Operating Officer
      Denise Wocko Named Head of Global Client Portfolio Management at RQM+
      Contract Pharma

      Latest Breaking News From Contract Pharma

      MilliporeSigma Announces Proteologix as Winner of North American Biotech Grant
      Veeva Business Consulting Expands with New R&D Services
      Samsung Biologics Accelerates Timeline of New Fifth Plant
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
      GetHarley Raises $52 Million in Latest Funding Round
      Refillable Skincare Products Face Hurdles Despite Growing Sustainability Awareness
      Happi

      Latest Breaking News From Happi

      Lil Nas X Leads YSL Beauty’s New Campaign
      La Roche-Posay Expands Anti-Aging Collection with Niacinamide 10 Serum
      Rite Aid Launches Beauty and Personal Care Essentials Collection
      Ink World

      Latest Breaking News From Ink World

      Siegwerk’s Center of Excellence in France Receives Facelift
      Epson announces MakeTheSwitch Campaign
      Pigments Market to Reach $26,598 Million by 2022: AMR
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Siegwerk opens revamped facility in France
      GEW founder Malcolm Rae wins Global Achievement Award
      CCL to personalize online customer experience
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      TechnoPlants to Exhibit at ITMA
      Andritz Buys 100% Stake in Dan-Web
      Luminy PLA Meets EU Sustainability Regulations
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Orthobiologics Market to Top $10.3 Billion by 2030
      Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
      Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition
      Christoph Ostermann Named Chairman of Heliatek‘s Advisory Board
      Flexible and Printed Electronics Represented at productronica 2023

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login